Together, our results suggest that UCA1 is a powerful tumor biomarker, and UCA1-miR-182-5p-DLL4 axis is involved in proliferation, migration, apoptosis and progression of renal cancer, which highlight its potential clinical utility as a promising diagnostic and therapeutic target of renal cancer. The gene discussed is DLL4; the disease is neoplasm.